Centralized multidisciplinary team assessment of metastasis resectability in patients with metastatic colorectal cancer: A fundamental necessity by Thierry André

Get full text

Deficient mismatch repair/microsatellite unstable colorectal cancer: therapeutic advances and questions by Baptiste Cervantes, Thierry André, Romain Cohen

Get full text

Immunotherapy for Early Stage Colorectal Cancer: A Glance into the Future by Romain Cohen, Qian Shi, Thierry André

Get full text

Therapeutic strategy in unresectable metastatic colorectal cancer by Benoist Chibaudel, Christophe Tournigand, Thierry André, Aimery de Gramont

Get full text

Molecular Targets for the Treatment of Metastatic Colorectal Cancer by Romain Cohen, Thomas Pudlarz, Jean-François Delattre, Raphaël Colle, Thierry André

Get full text

Immune Checkpoint Inhibition in Metastatic Colorectal Cancer Harboring Microsatellite Instability or Mismatch Repair Deficiency by Romain Cohen, Raphaël Colle, Thomas Pudlarz, Maximilien Heran, Alex Duval, Magali Svrcek, Thierry André

Get full text

Ovarian metastases of pancreatic adenocarcinoma: clinical presentation, role of surgery, and potential value of the mutational profile for the differential diagnosis with primary m... by Alice de Malet, Magali Svrcek, Anne Kerbaol, Nathalie Theou-Anton, Sandra Granier, Safi Dokmak, François Paye, Thierry André, Louis de Mestier, Jérôme Cros, Pascal Hammel

Get full text

Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOL... by Zeinab Hamidou, Benoist Chibaudel, Mohamed Hebbar, Marine Hug de Larauze, Thierry André, Christophe Louvet, David Brusquant, Marie-Line Garcia-Larnicol, Aimery de Gramont, Franck Bonnetain

Get full text

Treatments after Immune Checkpoint Inhibitors in Patients with dMMR/MSI Metastatic Colorectal Cancer by Quang Loc Bui, Léo Mas, Antoine Hollebecque, David Tougeron, Christelle de la Fouchardière, Thomas Pudlarz, Emily Alouani, Rosine Guimbaud, Julien Taieb, Thierry André, Raphaël Colle, Romain Cohen

Get full text

RECIST and CHOI criteria in the evaluation of tumor response in patients with metastatic colorectal cancer treated with regorafenib, a prospective multicenter study by Olivier Lucidarme, Mathilde Wagner, Paul Gillard, Stefano Kim, Jean-Baptiste Bachet, Benoit Rousseau, Thibault Mazard, Christophe Louvet, Benoist Chibaudel, Romain Cohen, Marie-Line Garcia-Larnicol, Aurelien Gobert, Julie Henriques, Thierry André

Get full text

Monitoring levels of circulating cell‐free DNA in patients with metastatic colorectal cancer as a potential biomarker of responses to regorafenib treatment by Brice Pastor, Thierry André, Julie Henriques, Isabelle Trouilloud, Christophe Tournigand, Marine Jary, Thibault Mazard, Christophe Louvet, Simon Azan, Audrey Bauer, Benoit Roch, Cynthia Sanchez, Dewi Vernerey, Alain R. Thierry, Antoine Adenis

Get full text

RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer:... by Christelle de La Fouchardière, Jaafar Bennouna, David Tougeron, Magali Svrcek, Thierry André, Christophe Tournigand, Christophe Borg, Romain Cohen, Marie-Line Garcia-Larnicol, Thibault Mazard, Yves Menu, Dewi Vernerey, Aurélia Meurisse, Benoist Chibaudel

Get full text

Immune microenvironment in patients with mismatch‐repair‐proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR cohort study by Marine Jary, Wen‐Wei Liu, Dongyao Yan, Isaac Bai, Andrea Muranyi, Elise Colle, Isabelle Brocheriou, Anthony Turpin, Nina Radosevic‐Robin, Pierre Bourgoin, Frédérique Penault‐Llorca, Romain Cohen, Dewi Vernerey, Thierry André, Christophe Borg, Kandavel Shanmugam, Magali Svrcek

Get full text

370 Time course of treatment-related adverse events (TRAEs) during dostarlimab therapy in the GARNET trial by Ana Oaknin, Maria-Pilar Barretina-Ginesta, Victor Moreno, Thierry André, Ruth Plummer, Florence Joly, Rowan Miller, Joanna Pikiel, Susana Banerjee, Jose Manuel Trigo Perez, Bhavana Pothuri, Andrea Jewell, Anna Tinker, Dominique Berton, Susan Ellard, Jennifer Veneris, Tao Duan

How Can the EU Beating Cancer Plan Help in Tackling Lung Cancer, Colorectal Cancer, Breast Cancer and Melanoma? by Denis Horgan, Anne-Marie Baird, Mark Middleton, Zhasmina Mihaylova, Jan P. Van Meerbeeck, Jens Vogel-Claussen, Paul E. Van Schil, Josep Malvehy, Paolo Antonio Ascierto, France Dube, Michael Zaiac, Jonathan A. Lal, Grażyna Kamińska-Winciorek, Marco Donia, Thierry André, Marta Kozaric, Pia Osterlund, Dan Lucian Dumitrascu, Luca Bertolaccini

Get full text

DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study by Stefano Kim, Véronique Vendrely, Angélique Saint, Thierry André, Pauline Vaflard, Emmanuelle Samalin, Simon Pernot, Oliver Bouché, Mustapha Zubir, Jérôme Desrame, Christelle de la Fouchardière, Denis Smith, François Ghiringhelli, Angélique Vienot, Marion Jacquin, Elodie Klajer, Thierry Nguyen, Éric François, Julien Taieb, Karine Le Malicot, Dewi Vernerey, Aurélia Meurisse, Christophe Borg

Get full text

Outcomes and a prognostic classifier in patients with microsatellite instability-high metastatic gastric cancer receiving PD-1 blockade by Akihito Kawazoe, Kohei Shitara, Sara Lonardi, Filippo Pietrantonio, Samuel J Klempner, Thierry André, Massimiliano Salati, Margherita Ambrosini, Giovanni Randon, Romain Cohen, Paolo Manca, Vincenzo Nasca, Joseph Chao, Leonardo Provenzano, Yu Aoki, Steven B Maron, Riccardo Cerantola, Lorenzo Fornaro, Walter Ferrari Bravo, Filippo Ghelardi, Valerie Zhu, Darren Cowzer, Virginia Genovesi

Get full text

Wnt, glucocorticoid and cellular prion protein cooperate to drive a mesenchymal phenotype with poor prognosis in colon cancer by Sophie Mouillet-Richard, Angélique Gougelet, Bruno Passet, Camille Brochard, Delphine Le Corre, Caterina Luana Pitasi, Camille Joubel, Marine Sroussi, Claire Gallois, Julien Lavergne, Johan Castille, Marthe Vilotte, Nathalie Daniel-Carlier, Camilla Pilati, Aurélien de Reyniès, Fatima Djouadi, Sabine Colnot, Thierry André, Julien Taieb, Jean-Luc Vilotte, Béatrice Romagnolo, Pierre Laurent-Puig

Get full text

Prognostic role of HPV integration status and molecular profile in advanced anal carcinoma: An ancillary study to the epitopes-HPV02 trial by Alice Debernardi, Aurélia Meurisse, Aurélia Meurisse, Jean-Luc Prétet, Jean-Luc Prétet, David Guenat, David Guenat, Franck Monnien, Laurie Spehner, Laurie Spehner, Angélique Vienot, Angélique Vienot, Patrick Roncarati, Thierry André, Laurent Abramowitz, Laurent Abramowitz, Chloé Molimard, Christiane Mougin, Christiane Mougin, Michael Herfs, Stefano Kim, Stefano Kim, Stefano Kim, Christophe Borg, Christophe Borg, Christophe Borg

Get full text

Sex-related disparities in outcomes of cholangiocarcinoma patients in treatment trials by Matthew Ledenko, Samuel O. Antwi, Shiho Arima, Julia Driscoll, Junji Furuse, Heinz-Josef Klümpen, Finn Ole Larsen, David K. Lau, David K. Lau, Annett Maderer, Annett Maderer, Alice Markussen, Markus Moehler, Markus Moehler, Lynn E. Nooijen, Walid L. Shaib, Niall C. Tebbutt, Thierry André, Makoto Ueno, Rachel Woodford, Changhoon Yoo, Mark M. Zalupski, Tushar Patel

Get full text